| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 10/15/2009 | WO2009126527A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors |
| 10/15/2009 | WO2009125861A1 Cysteine protease inhibitor |
| 10/15/2009 | US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 10/15/2009 | US20090258429 Colorimetric detection of cyanide with a chromogenic oxazine |
| 10/15/2009 | CA2720530A1 Sulfonamides |
| 10/15/2009 | CA2719376A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors |
| 10/14/2009 | EP1658267B1 Inhibitors of cathepsin s |
| 10/14/2009 | CN100548994C Benzo oxaxine intermediate containing aldehyde group and its preparation method |
| 10/13/2009 | US7601713 Kinase inhibitors and their uses |
| 10/13/2009 | US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists |
| 10/08/2009 | US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content |
| 10/08/2009 | US20090253811 Manufacture process of organic compounds |
| 10/08/2009 | US20090253693 2H-BENZO[b][1,4]OXAZIN-3(4H)-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 10/08/2009 | US20090253687 Fused Heterocyclic Compounds and Their Use as Mineralocorticoid Receptor Ligands |
| 10/08/2009 | US20090253684 Leukotriene b4 inhibitors |
| 10/08/2009 | US20090253118 Luminescence quenchers and fluorogenic probes for detection of reactive species |
| 10/06/2009 | US7598378 Reacting 4-(4-nitrophenyl)-3-morpholinone with hydrogen in the presence of a hydrogenation catalyst, characterized in that reaction is effected in an aliphatic alcohol; precursor in synthesis of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide |
| 10/06/2009 | US7598241 Carboxamide derivatives and their use as factor Xa inhibitors |
| 10/01/2009 | US20090247745 adenosine A3 receptor antagonists; improved bioavailability; treatment of diseases such as asthma, COPD and ARDS, glaucoma, tumor, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases; e.g. 4-Methoxy-N-[6-(morpholin-4-yl)-4-benzylamino-3-cyanoquinolin-2-yl]-benzamide |
| 10/01/2009 | US20090247470 Phenylalanine dipeptide derivatives, compositions and use thereof |
| 09/29/2009 | US7595397 Compounds which modulate the CB2 receptor |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | US7595315 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 09/24/2009 | WO2009117467A2 Therapeutic compounds |
| 09/24/2009 | WO2009114950A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
| 09/24/2009 | US20090239841 Diaryl Ureas as CB1 Antagonists |
| 09/24/2009 | CA2718959A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
| 09/22/2009 | US7592476 Process for producing enantiopure β-amino acid derivatives, and enantiopure β-amino acid derivatives |
| 09/22/2009 | US7592449 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 09/17/2009 | WO2009113569A1 Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease |
| 09/17/2009 | US20090233920 Organic compounds |
| 09/17/2009 | US20090233919 Thiazolopyridinone derivates as mch receptor antagonists |
| 09/17/2009 | US20090233915 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis |
| 09/17/2009 | US20090233909 Sulfonamide compounds as cysteine protease inhibitors |
| 09/17/2009 | US20090233900 2-aminobenzamide derivative |
| 09/16/2009 | EP2100611A1 Glucose metabolism ameliorating agent |
| 09/16/2009 | CN101535283A Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide |
| 09/16/2009 | CN101531565A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540546C Arylsulfonyl benzodioxanes for regulating the 5-HT6 receptor, the 5-HT2areceptor or both |
| 09/15/2009 | US7589197 Pyrimidine compounds |
| 09/15/2009 | US7589196 1,1'-Biphenyl-2,2'-diphosphines having at least one amine substituent in the para position relative to the phosphine group; as ligands for metal complexes which are catalysts for enantioselective syntheses such as hydrogenation, isomerization |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/11/2009 | WO2009070579A3 Morpholines as selective inhibitors of cytochrome p450 2a13 |
| 09/11/2009 | CA2715835A1 Amide compounds, compositions and uses thereof |
| 09/10/2009 | US20090227790 A kit for treating a disorder characterized by loss of dopaminergic and/or motoneurons, for treating Parkinson's disease, amyotrophic lateral sclerosis (ALS), or limiting damage to neuronal cells by Parkinsonian conditions |
| 09/09/2009 | CN101525318A Method for preparing 2, 6-dimethyl-N-tridecyl drewamine |
| 09/09/2009 | CN100537550C Process for the production of DTPA-bis anhydride |
| 09/09/2009 | CN100537549C Method for production of n-aryl morpholinones |
| 09/09/2009 | CN100537519C Intermediate for preparing benzo-oxazine derivative and its preparing method |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/03/2009 | WO2009107448A1 Thiol detection method |
| 09/03/2009 | WO2009106486A1 Preparation of morpholine derivatives |
| 09/03/2009 | WO2009105906A1 Flavor molecules |
| 09/03/2009 | US20090221817 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates |
| 09/03/2009 | US20090221566 Inhibitors of phosphodiesterase type-iv |
| 09/03/2009 | US20090221551 Substituted fused[1,2] imidazo[4,5c] ring compounds and methods |
| 09/03/2009 | CA2715781A1 Preparation of morpholine derivatives |
| 09/02/2009 | EP2096104A1 Organic diamines as mGluR7 modulators |
| 09/02/2009 | EP2094660A2 Immunochemically equivalent hiv drug analogs |
| 09/02/2009 | EP2094646A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 09/02/2009 | EP2094272A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 09/01/2009 | US7582755 Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 08/27/2009 | WO2009105218A2 Propiophenone derivatives |
| 08/27/2009 | WO2009103479A2 Cristallines, enantiomerically pure salt form of a betamimetic agent, and the use thereof as a medicament |
| 08/27/2009 | WO2009075835A8 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 08/27/2009 | US20090216015 Base Stable Ionic Liquids |
| 08/27/2009 | US20090215967 Manufacture of novel epoxy resins semi-thermosets and their high tg thermosets for electronic applications |
| 08/27/2009 | US20090215764 Antimicrobial agents |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215724 Pyrrolopyrazine kinase inhibitors |
| 08/27/2009 | CA2712706A1 Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug |
| 08/26/2009 | EP2093223A1 Process for production of anthranilamide compound |
| 08/26/2009 | EP2093219A1 Crystalline enantiomer free salt form of a betamimetic and its use as medicine |
| 08/26/2009 | EP2091928A2 3-(2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors |
| 08/26/2009 | CN100532384C Beta-enol imine structure boron fluoride complex and method of synthesizing the same |
| 08/26/2009 | CN100532369C Benzoxazine derivatives and uses thereof |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579346 Carboxamides |
| 08/25/2009 | US7579340 Cardiovascular homeostasis through combination of direct neuronal control and systemic neurohormonal activation; inflammatory bowel disease |
| 08/25/2009 | CA2538072C Amide-type carboxamide derivatives |
| 08/20/2009 | WO2009102460A2 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/20/2009 | WO2009101432A2 Process for preparing pyridone derivatives |
| 08/20/2009 | CA2715290A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 08/20/2009 | CA2713722A1 Process for preparing pyridone derivatives 226 |
| 08/19/2009 | CN100528821C Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/18/2009 | US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide |
| 08/18/2009 | US7576081 Morpholine dopamine agonists |
| 08/13/2009 | WO2009099110A1 Ultraviolet absorbent, fused ring compound and method for producing the same |
| 08/13/2009 | US20090203904 Arylsulfinate salts in photoinitiator systems for polymerization reactions |
| 08/13/2009 | US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics |
| 08/13/2009 | US20090203681 Novel n-(2-amino-phenyl)-amide derivatives |
| 08/13/2009 | US20090203666 Compounds and compositions as hedgehog pathway modulators |
| 08/12/2009 | EP2086949A1 Method of preparing benzoxazines |
| 08/12/2009 | EP1794136B1 Aryl-ureido benzoxazinone compounds |
| 08/12/2009 | EP1515959B1 Pharmaceutical salts of reboxetine |
| 08/12/2009 | EP1367132B1 Process for preparation of optically active propoxyaniline derivatives |